Paragen Bio logo — Advanced technology for halting autoimmune diseases's impact...

Paragen Bio

Advanced technology for halting autoimmune diseases's impact on healthy tissues and organs, empowering doctors to preserve and protect patient health

Founded 2018 Venture round Total: $6.00M Biopharma, Biotechnology +1

General Information

Company Name Paragen Bio
Founded Year 2018
Industries Biopharma, Biotechnology, Life Sciences
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Paragen Bio. To contact Paragen Bio, visit paragenbio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Paragen Bio compare?

A PDF of Paragen Bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Paragen Bio soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Paragen Bio

Paragen Bio is a biopharmaceutical startup with a mission to combat the impact of autoimmune diseases on healthy tissues and organs. Founded in 2018, the company has attracted notable attention from investors, securing a significant $6.00M in its last venture round investment on 14 August 2018. This round was backed by reputable investors such as AbbVie Ventures, OneVentures, and the Medical Research Commercialisation Fund (MRCF), showcasing the industry's confidence in Paragen Bio's advanced technology. The company's innovative solution offers a promising approach to managing autoimmune conditions by empowering physicians to prevent further deterioration and destruction of healthy tissues and organs. With a focus on biopharma, biotechnology, and life sciences, Paragen Bio is poised to make notable strides in the healthcare industry.

Business keywords: autoimmune diseases, technology, immune system, tissue preservation, organ protection, medical innovation, disease management

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $6.00M 3
AbbVie Ventures, OneVentures +1
14 Aug 2018

Paragen Bio Alternatives & Competitors

View All Alternatives
Paragen Bio vs

New solutions for autoimmune, inflammatory and bone diseases.

Post-IPO Equity
16 employees
Biopharma, Biotechnology
Paragen Bio vs
Emergo Therapeutics
Emergo Therapeutics United States

Bringing the Immune Response Back into Balance

Venture round
5 employees
Biopharma, Biotechnology
Paragen Bio vs
Tr1X
Tr1X United States

Engineering cures for patients with autoimmune & inflammatory diseases.

46 employees
Biotechnology, Health Care

FAQ About Paragen Bio

Advanced technology for halting autoimmune diseases's impact on healthy tissues and organs, empowering doctors to preserve and protect patient health
Paragen Bio was founded in 2018.
Paragen Bio operates in Biopharma, Biotechnology and Life Sciences. Its work centres on autoimmune diseases, technology, immune system and tissue preservation.
Paragen Bio has completed 1 funding round, raising a total of $6.00M. The latest funding stage is Venture round.
Top alternatives and competitors to Paragen Bio include BIOSENIC S.A., Emergo Therapeutics, Tr1X, Revolo Biotherapeutics, Xenikos B.V.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Paragen Bio and BIOSENIC S.A. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Paragen Bio, https://bouncewatch.com/company/paragen-bio, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes